GH Latest Press Releases

-- December 11, 2025 --

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. Business Wire 8:05 AM

-- December 9, 2025 --

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy Business Wire 8:05 AM

-- December 5, 2025 --

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium Business Wire 8:05 AM

-- November 12, 2025 --

Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access Business Wire 8:05 AM

-- November 10, 2025 --

Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring Business Wire 8:05 AM

-- November 7, 2025 --

Guardant Health to Participate in Upcoming Investor Conferences Business Wire 8:00 AM

-- November 6, 2025 --

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:35 PM

New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response Business Wire 8:05 AM

-- November 5, 2025 --

Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients Business Wire 4:05 PM

Guardant Health Announces Pricing of Upsized Public Offering of Common Stock Business Wire 2:15 AM

Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering Business Wire 2:15 AM

-- November 4, 2025 --

Guardant Health Announces Proposed Public Offering of Common Stock Business Wire 4:39 PM

Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033 Business Wire 4:38 PM

-- October 29, 2025 --

Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Business Wire 4:05 PM

-- October 27, 2025 --

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights Business Wire 8:05 AM

-- October 26, 2025 --

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025 Business Wire 3:01 PM

-- October 16, 2025 --

4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH) AB Digital Inc 4:12 PM

-- October 15, 2025 --

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025 Business Wire 4:57 PM

-- October 9, 2025 --

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 Business Wire 4:05 PM

Propel Software Accelerates Adoption of Agentic AI for PLM, QMS & PIM with Early Customers Using Live Data Business Wire 9:04 AM

-- September 29, 2025 --

FDA Approves Guardant360 CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer Business Wire 8:05 AM

-- September 24, 2025 --

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield Blood-based Screening Test in the United States Business Wire 8:05 AM

-- September 15, 2025 --

Alex M. Azar II Joins Guardant Health Board of Directors Business Wire 4:07 PM

-- September 11, 2025 --

Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership Business Wire 8:05 AM

-- September 8, 2025 --

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States Business Wire 8:05 AM

-- September 4, 2025 --

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test Business Wire 8:06 AM

-- August 28, 2025 --

Guardant Health to Host Investor Day on September 24, 2025 Business Wire 4:05 PM

-- August 26, 2025 --

Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Business Wire 4:05 PM

-- August 15, 2025 --

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:05 PM

-- August 4, 2025 --

American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity Business Wire 8:06 AM

-- July 31, 2025 --

Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference Business Wire 4:05 PM

-- July 30, 2025 --

Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Business Wire 4:05 PM

Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+ Business Wire 8:09 AM

-- July 29, 2025 --

New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer Business Wire 8:07 AM